InvestorsHub Logo
icon url

madtrader2132

04/18/17 7:26 AM

#85041 RE: Homebrew #85036

That's for other medical issues. The psoriasis was a go and they started trials April 2017
icon url

zioni007

04/18/17 7:28 AM

#85042 RE: Homebrew #85036

Psoriasis Studies are pretty much wrapped up they will need to submit other studies to the USA for FDA approval, Since there market is for the EU/UK as of now, these other ongoing test are on other skin disorders not psoriasis .
icon url

Manaman

04/18/17 7:41 AM

#85045 RE: Homebrew #85036

You are confusing between studies
This is referring to preclinical study and to the announcement that was issued on 02/2017.
Results for PRE clinical efficacy are already out - up to 70% improvement
Product readiness depends on safety study that already started
icon url

moxa1

04/18/17 8:02 AM

#85056 RE: Homebrew #85036

That is for OTHER skin disorders, not psoriasis.
icon url

FELLER

04/18/17 8:18 AM

#85069 RE: Homebrew #85036

The answer to the question is at the end of the sentence. I'll highlight in bold & red.

March 21 OWCP said: "As a result of the promising results of our psoriasis tests, our Chairman and CEO, Mr. Mordechai Bignitz, has directed OWC's scientific team to submit an operating plan within 60 to 90 days to conduct double-blind efficacy tests of our cannabinoid-based topical cream on other skin disorders and conditions."